Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Surgery
NCT03063073Phase 3Completed
- Sponsor
- South Egypt Cancer Institute
- Start
- Feb 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in breast cancer, sponsored by South Egypt Cancer Institute. Started Feb 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03063073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03063073.